| Literature DB >> 33855271 |
Cathal Seoighe1, Adrian P Bracken2, Patrick Buckley3, Peter Doran4,5, Robert Green6, Sandra Healy1, David Kavanagh3, Elaine Kenny2,7, Mark Lawler8, Maeve Lowery2,9, Derek Morris1, Darrin Morrissey10, James J O'Byrne5, Denis Shields4, Owen Smith4,11, Charles A Steward12, Brian Sweeney13, Walter Kolch1.
Abstract
Genomics is revolutionizing biomedical research, medicine and healthcare globally in academic, public and industry sectors alike. Concrete examples around the world show that huge benefits for patients, society and economy can be accrued through effective and responsible genomic research and clinical applications. Unfortunately, Ireland has fallen behind and needs to act now in order to catch up. Here, we identify key issues that have resulted in Ireland lagging behind, describe how genomics can benefit Ireland and its people and outline the measures needed to make genomics work for Ireland and Irish patients. There is now an urgent need for a national genomics strategy that enables an effective, collaborative, responsible, well-regulated, and patient centred environment where genome research and clinical genomics can thrive. We present eight recommendations that could be the pillars of a national genomics health strategy. Copyright:Entities:
Keywords: Genomics; ethics of genome research; genome research; health-economic assessment of clinical genomics; national genomics strategy; patient involvement; precision/personalized medicine; societal and economic aspects of genome research
Year: 2020 PMID： 33855271 PMCID： PMC7993626 DOI： 10.12688/hrbopenres.13187.1
Source DB: PubMed Journal: HRB Open Res ISSN： 2515-4826